Abstract | BACKGROUND: Diabetes is one of the biggest medical challenges worldwide. The key to efficiently treat type 1 diabetes is to accurately inject insulin according to the blood glucose levels. In this study, we aimed to develop an intelligent insulin-releasing gold nanocluster system that responds to environmental glucose concentrations. RESULTS: We employed gold nanoclusters (AuNCs) as a novel carrier nanomaterial by taking advantage of their high drug-loading capacity. We prepared AuNCs in the protection of bovine serum albumin, and we decorated AuNCs with 3-aminophenylboronic acid (PBA) as a glucose-responsive factor. Then we grafted insulin onto the surface to obtain the glucose-responsive insulin-releasing system, AuNC-PBA-Ins complex. The AuNC-PBA-Ins complex exhibited high sensitivity to glucose concentration, and rapidly released insulin in high glucose concentration in vitro. In the type 1 diabetic mouse model in vivo, the AuNC-PBA-Ins complex effectively released insulin and regulated blood glucose level in the normoglycemic state for up to 3 days. CONCLUSIONS:
|
Authors | Yujie Zhang, Mingxin Wu, Wubin Dai, Min Chen, Zhaoyang Guo, Xin Wang, Di Tan, Kui Shi, Longjian Xue, Sheng Liu, Yifeng Lei |
Journal | Journal of nanobiotechnology
(J Nanobiotechnology)
Vol. 17
Issue 1
Pg. 74
(Jun 03 2019)
ISSN: 1477-3155 [Electronic] England |
PMID | 31159842
(Publication Type: Journal Article)
|
Chemical References |
- Blood Glucose
- Boronic Acids
- Hypoglycemic Agents
- Insulin
- Serum Albumin, Bovine
- 3-aminobenzeneboronic acid
- Gold
|
Topics |
- Animals
- Blood Glucose
(analysis)
- Boronic Acids
(chemistry)
- Cattle
- Diabetes Mellitus, Type 1
(drug therapy)
- Gold
(chemistry)
- Hypoglycemic Agents
(administration & dosage, chemistry)
- Insulin
(administration & dosage, chemistry)
- Male
- Metal Nanoparticles
(chemistry)
- Mice, Inbred C57BL
- Serum Albumin, Bovine
(chemistry)
|